These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH, Edelstein MA. Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [Abstract] [Full Text] [Related]
4. Comparative efficacy of five antibiotics on experimental airborne legionellosis in guinea-pigs. Nowicki M, Paucod JC, Bornstein N, Meugnier H, Isoard P, Fleurette J. J Antimicrob Chemother; 1988 Oct; 22(4):513-9. PubMed ID: 3204078 [Abstract] [Full Text] [Related]
5. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease. Kohno S, Koga H, Yamaguchi K, Masaki M, Inoue Y, Dotsu Y, Masuyama Y, Hayashi T, Hirota M, Saito A. J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201 [Abstract] [Full Text] [Related]
6. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. Fitzgeorge RB, Featherstone AS, Baskerville A. J Antimicrob Chemother; 1990 Jan; 25 Suppl A():101-8. PubMed ID: 2154427 [Abstract] [Full Text] [Related]
7. Comparison of the activity of three antibiotic regimens in severe Legionnaires' disease. Dournon E, Mayaud C, Wolff M, Schlemmer B, Samuel D, Sollet JP, Levasseur-Rajagopalan P. J Antimicrob Chemother; 1990 Oct; 26 Suppl B():129-39. PubMed ID: 2258340 [Abstract] [Full Text] [Related]
8. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. Edelstein PH, Edelstein MA, Lehr KH, Ren J. J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752 [Abstract] [Full Text] [Related]
9. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp. Higa F, Arakaki N, Tateyama M, Koide M, Shinzato T, Kawakami K, Saito A. J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952 [Abstract] [Full Text] [Related]
10. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. Saito A, Koga H, Shigeno H, Watanabe K, Mori K, Kohno S, Shigeno Y, Suzuyama Y, Yamaguchi K, Hirota M. J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736 [Abstract] [Full Text] [Related]
12. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH, Shinzato T, Edelstein MA. J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [Abstract] [Full Text] [Related]
13. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs. García-de-Lomas J, Millás E, Lázaro MA, Bermejo M, Gimeno C, Navarro D, Sánchez S. Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):420-3. PubMed ID: 9758285 [Abstract] [Full Text] [Related]
18. Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents. Vildé JL, Dournon E, Rajagopalan P. Antimicrob Agents Chemother; 1986 Nov; 30(5):743-8. PubMed ID: 3492176 [Abstract] [Full Text] [Related]
19. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Edelstein PH, Shinzato T, Doyle E, Edelstein MA. Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675 [Abstract] [Full Text] [Related]